Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol/fluticasone versus ipratropium/albuterol for circulating inflammatory biomarkers in stable COPD
ChiCTR-TRC-09000442Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of salmeterol, fluticasone propionate, ipratropium bromide and salbutamol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: C-reactive protein. Started Jun 2007; status: completed.
02
Drugs
salmeterolfluticasone propionateipratropium bromidesalbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-TRC-09000442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000442.